OutPerformDaily

  • Tech Stocks
  • Cannabis Stocks
  • Index Funds
  • International
  • Short
  • Stock Picks

Lost Password?

Top 3 AI Stocks to Invest in Right Now

Fake shopping sprees and ‘happiness insurance’: The latest fintech apps reveal our financial anxieties

Is Apple’s foldable iPhone Duo worth $2,000? See how it stacks up against other foldable phones.

I gave my HomeExchange guest a 5-star review. Then I found heat marks all over my dining table. Do I call her out?

Inside the push to weaken Washington’s toughest financial watchdog

Scared to spend your retirement money? Here’s one way to get over the fear of running out.

OutPerformDaily
  • Tech Stocks
  • Cannabis Stocks
  • Index Funds
  • International
  • Short
  • Stock Picks
OutPerformDaily
  • Tech Stocks
  • Cannabis Stocks
  • Index Funds
  • International
  • Short
  • Stock Picks
3rdPartyFeeds

The Most Expensive US State To Live In

June 2, 2024

In this article, we look at the most expensive US state to live in. We have created a list of the costliest states in America, for the full free list, visit 20...

3rdPartyFeeds

Forget AMD: 2 Artificial Intelligence (AI) Stocks to Buy Now

June 2, 2024

These companies are trading at better valuations than AMD and are potentially better options to invest in AI chips. Read More...

3rdPartyFeeds

Should You Buy Amazon Stock Now or Wait for a Dip?

June 2, 2024

Amazon's stock is back to trading around all-time highs. Read More...

3rdPartyFeeds

Better Artificial Intelligence (AI) Stock: Meta Platforms vs. Microsoft

June 2, 2024

Investors looking to buy one of these two stocks to capitalize on the proliferation of AI have a tough choice to make. Read More...

3rdPartyFeeds

2 Millionaire-Maker Technology Stocks

June 2, 2024

These companies are leading the way in AI and could deliver major gains in the coming years. Read More...

3rdPartyFeeds

Forget Nvidia: 1 Artificial Intelligence (AI) Stock to Buy Instead

June 2, 2024

This leading internet enterprise deserves a closer look from investors. Read More...

3rdPartyFeeds

Is Recursion Pharmaceuticals Stock a Millionaire-Maker?

June 2, 2024

Recursion Pharmaceuticals hopes to transform the healthcare industry with the help of AI. Read More...

3rdPartyFeeds

1 Important Growth Trend Nvidia Investors May Have Missed in the Latest Quarterly Report

June 2, 2024

Nvidia's outstanding data center growth stole the show last quarter, but there is another business where AI is starting to move the needle. Read More...

3rdPartyFeeds

The Top US Economic Indicator Every Investor Should Know

June 1, 2024

We recently compiled a list of the Top 15 U.S. Economic Indicators Every Investor Should Know and in this article we will talk about the top US economic...

3rdPartyFeeds

Did Amazon Just Say “Checkmate” to Nvidia?

June 1, 2024

Amazon just announced another strategic alliance as it builds out its AI roadmap. Read More...

Previous 1 … 1,067 1,068 1,069 1,070 1,071 … 8,455 Next
Indices by TradingView

Categories

  • 3rdPartyFeeds
  • Cannabis Stocks
  • Index Funds
  • International
  • News
  • Short
  • Stock Picks
  • Tech Stocks
  • Uncategorized
Indices by TradingView
While subscribers receive the benefit of Outperformdaily opinions, none of the information contained therein constitutes a recommendation from Outperformdaily that any particular security, portfolio of securities, transaction, option, or investment strategy is suitable for any specific person. You further understand that we will not advise you personally concerning the nature, potential, value or suitability of any particular security, portfolio of securities, transaction, investment strategy or other matter. To the extent any of the information contained in Outperformdaily may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person. Outperformdaily’s past results are not necessarily indicative of future performance. All investments are subject to loss. Our employees and writters typically personally invest in all recommendations, but they are not obligated too. Our employees and writters are prohibited from taking an opposite position from which they write about.